CVSCVS Health

Health care · Pharmacies · NYSE

Employees: 300,000
Headquarters: Woonsocket, RI
CEO: J. David Joyner
Next results: around Feb 9, 2027

Key numbers

Latest fiscal year, with ten years behind each

RevenueFY2016–25 $402.1B+7.8% Highest in 10 years 10-K FY2025 · XBRL Net incomeFY2016–25 $1.8B−61.7% FY2024: $4.6B 10-K FY2025 · XBRL Free cash flowFY2016–25 $7.8B+23.4% FY2024: $6.3B 10-K FY2025 · XBRL Operating marginFY2016–25 1.2%−1.1 pts 5.8% in FY2016 10-K FY2025 · XBRL

What changed

10-K filed Feb 10, 2026 against Feb 12, 2025

Area	What changed	Source
Risk factors	9 new paragraphs, nothing like them in the previous 10-K	10-K Item 1A
Accounting checks	11 other checks clear	10-K · XBRL
Insiders	1 open-market buy in the last 90 days	Form 4
Filings	4 in the last 30 days	EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

What's new, in their words

10-K filed Feb 10, 2026

Paragraphs in Risk Factors that were not in the 10-K filed 2025-02-12. Quoted as filed.

There can be no assurance that we have been able to, or will be able to, adequately prevent, detect, and/or remediate such data security incidents.
10-K, Item 1A

All 9 new paragraphs →

Accounting checks

latest 10-K

11 of 11 clear 0 worth a look. Checks, not verdicts.

✓
Receivables +9.1% vs revenue +7.8% (+1.2 pts)
✓
Cash from operations $10.6B vs net income $1.8B (FY ending 2025-12-31)
✓
Inventory +6.3% vs revenue +7.8% (-1.6 pts)
✓
Same auditor in both 10-Ks: Ernst & Young LLP
✓
No statement of substantial doubt about going concern
✓
No 8-K item 4.02 in the last 2 years
✓
No NT 10-K or NT 10-Q in the last 2 years
✓
No longer listed: Valuation of goodwill for the Government reporting unit. Same as last year: Valuation of health care costs payable
✓
No sentence in the 10-K concludes that controls were not effective because of a material weakness
✓
No 8-K item 2.06 in the last 2 years
✓
No 8-K item 1.03 in the last 2 years

How each check works, with sources →

In the last 30 days

All filings →

Nov 6, 2026Buy Shah Prem S (EVP and Group President) bought $2.0M open-market purchase on Nov 6, 2026
Nov 4, 20268-K Quarterly results 8-K item 2.02
Nov 4, 20268-K Regulation FD disclosure 8-K item 7.01
Nov 4, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026

About CVS Health

10-K, Feb 10, 2026

CVS Health Corporation, together with its subsidiaries (collectively, “CVS Health,” the “Company,” “we,” “our” or “us”), is a leading health solutions company building a world of health around every consumer it serves and connecting care so that it works for people wherever they are. As of December 31, 2025, we had approximately 9,000 retail locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 87 million plan members and expanding specialty pharmacy solutions.

Headquarters: Woonsocket, RI
Country: United States
Reports in: USD
Listed on: NYSE
Fiscal year ends: December 31
Last results: Nov 4, 2026
Incorporated in: DE

Employees, at the top of the page: "As of December 31, 2025, we employed over 300,000 colleagues primarily in the U" (10-K). Address and exchange: SEC's company file.

Permanent link, kept if the ticker changes: /c/sec:0000064803 (SEC's CIK).

Get an email when this changes: new risk paragraphs, accounting items, insider purchases, a new 10-K or 10-Q. RSS feed

Work on CVS in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/CVS/export.csv") into a cell.